Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Vital-signs-integrated Patient-assisted Intravenous Opioid Analgesia

NCT: NCT02804022 · ACTIVE_NOT_RECRUITING

NCT IDNCT02804022
StatusACTIVE_NOT_RECRUITING
Start Date2016-12-29
Completion2027-12-31
SponsorKK Women's and Children's Hospital (OTHER_GOV)
First posted
Last updated

Brief Summary

This is a closed-loop system which is embodied in a novel and intelligent algorithm that takes into account patients' vital signs. The system allows better and responsive titration of personalized pain relief together with non-invasive physiological monitoring that measures oxygenation, breathing and heart rate continuously.

Frequently Asked Questions

What is Vital-signs-integrated Patient-assisted Intravenous Opioid Analgesia?

Vital-signs-integrated Patient-assisted Intravenous Opioid Analgesia is a clinical trial registered under NCT02804022. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT02804022?

The current status of NCT02804022 (Vital-signs-integrated Patient-assisted Intravenous Opioid Analgesia) is: ACTIVE_NOT_RECRUITING.

When did Vital-signs-integrated Patient-assisted Intravenous Opioid Analgesia start?

Vital-signs-integrated Patient-assisted Intravenous Opioid Analgesia started on 2016-12-29.

Related Devices

K171621Welch Allyn Connex Vital Signs Monitor, Welch Allyn Connex Integrated Wall System, 901060 Vital Signs MonitorWelch Allyn, Inc. K211906Vital SignsOxehealth Limited K243687Vital SignsOxehealth Limited K251200Vital SignsOxehealth Limited

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑